Since 2009, the Cubis® line of premium lab balances from Sartorius has been a performance benchmark in this field.

Vaccines are a potent and cost-effective method of preventing deadly diseases. The recent global outbreak of COVID-19 caused by the severe acute respiratory syndrome coronavirus (SARS-CoV-2) serves as a stark reminder of the imminent threat of unexpected pathogens.

Octet® systems have been widely used in the biopharma industry and academic research. From discovery through development and to manufacturing.

Since 2009, the Cubis® line of premium lab balances from Sartorius has been a performance benchmark in this field.

Systems Superior Performance Unrivaled Flexibility

Lipid nanoparticle (LNP) based therapeutics and vaccines have been at the forefront of the non-viral delivery since SARS-CoV-2 vaccines rolled out and proved their worth. LNP’s safety profile is a critical attribute that must be considered during its formulation and manufacturing

Advanced Strategies for Fcγ Receptor Binding Assays in Antibody Research

lthough autologous therapies offer great advantages in terms of host compatibility, their manufacturing presents challenges along several parameters, including control strategy and supply chain.

CAR-T therapies have shown tremendous clinical potential. However, the manufacturing remains challenging due to the lack of control and automation as well as process and cell product characterization during process development and manufacturing stages

More Insight, Better Decisions for Monoclonal Antibody (mAb) Therapy Discovery and Development

Inaccurate pipetting can compromise research outcomes, product quality, and regulatory compliance.

Techniques and Applications

Discover how a modern affinity-based approach can help you achieve high-quality mRNA while improving process efficiency across development and manufacturing.

A holistic data infrastructure removes the barriers of finding, capturing, converting and organizing operational data, enabling operators and engineers to model enterprise-wide operational intelligence while reducing complexity and cost.

All eyes are on scientists as the world responds to the COVID-19 pandemic. The clock is ticking and every experiment counts. This is where speed and reproducibility are critical

The Cubis® II balance, with pharma package, contains all the technical controls to support compliance with common regulations

The new generation of live-cell analysis technologies are allowing scientists to capture dynamic insights using non-perturbing, long-term cell studies.

The ability to manufacture large quantities of MSCs is required for therapeutic applications, and the development of robust, optimized production processes is essential to enable scale-up.

As immune cell therapy advances to address new indications, the need for rapid development of robust manufacturing processes becomes increasingly important.

The outbreak and distribution of the acute respiratory syndrome coronavirus (SARS-CoV-2) has emerged as one of the biggest challenges to global healthcare and economic systems.

The use of a highly pure mobile phase is essential for ensuring the highest analytical-grade quality. The eluents must be especially pure in terms of their physical and chemical properties and must not contain any organic impurities or particles.